[Objective] This study proposes a new method to predict the relationship between drugs and targets to improve the prediction performance. [Methods] Firstly, we used the SNF, AVG, and MAX methods to fuse multiple semantic relationships in drug and target similarity networks, which further enriched the semantic information of the networks. Then, we constructed a bidirectional diffusion model based on the fused similarity networks and the existing drug-target interaction network to predict the drug-target relationship. [Results] Compared with mainstream forecasting models, our method's AUC value index improved by 2.2% and 12.8%. With a retrospective study, the prediction scores ranked in the top 10, 20, and 30 drug-target relationship pairs, and clues and evidence related to 3, 8, and 11 drug-target pairs could be found in the literature. The SNF had the best fusion effect and maximized the prediction. [Limitations] We did not fuse similarities in objective attributes of drugs or targets, such as the chemical structure of drugs or sequence structure similarities of targets. The cold start problem in the relationship between new drugs and new targets still needs to be solved. [Conclusions] The prediction method proposed in this study could provide some references for the research on drug repositioning and relationship prediction of other biomedical entities.
(Wang Na, Chang Fuhou, Qian Xinyu, et al. Research Progress of New Drug Research and Development in China[J]. Chinese Journal of Pharmacology and Toxicology, 2019, 33(10): 839.)
[2]
Pushpakom S, Iorio F, Eyers P A, et al. Drug Repurposing: Progress, Challenges and Recommendations[J]. Nature Reviews Drug Discovery, 2019, 18(1): 41-58.
doi: 10.1038/nrd.2018.168
pmid: 30310233
[3]
Wang C, Kurgan L. Survey of Similarity-Based Prediction of Drug-Protein Interactions[J]. Current Medicinal Chemistry, 2020, 27(35): 5856-5886.
doi: 10.2174/0929867326666190808154841
(Zhang Han, An Xinyu, Liu Chunhe. Building Multi-Source Semantic Knowledge Graph for Drug Repositioning[J]. Data Analysis and Knowledge Discovery, 2022, 6(7): 87-98.)
[5]
Wang B, Jiang J Y, Wang W, et al. Unsupervised Metric Fusion by Cross Diffusion[C]// Proceedings of the 2012 IEEE Conference on Computer Vision and Pattern Recognition. Piscataway: IEEE, 2012: 2997-3004.
[6]
Wang B, Mezlini A M, Demir F, et al. Similarity Network Fusion for Aggregating Data Types on a Genomic Scale[J]. Nature Methods, 2014, 11(3): 333-337.
doi: 10.1038/nmeth.2810
pmid: 24464287
[7]
Wu G S, Liu J, Wang C H. Semi-Supervised Graph Cut Algorithm for Drug Repositioning by Integrating Drug, Disease and Genomic Associations[C]// Proceedings of the 2016 IEEE International Conference on Bioinformatics and Biomedicine (BIBM). Piscataway: IEEE, 2016: 223-228.
[8]
Wu G S, Liu J, Wang C H. Predicting Drug-Disease Interactions by Semi-Supervised Graph Cut Algorithm and Three-Layer Data Integration[J]. BMC Medical Genomics, 2017, 10(5): Article No.79.
[9]
Tangmanussukum P, Kawichai T, Suratanee A, et al. Heterogeneous Network Propagation with Forward Similarity Integration to Enhance Drug-Target Association Prediction[J]. PeerJ Computer Science, 2022, 8: e1124.
doi: 10.7717/peerj-cs.1124
pmid: 36262151
[10]
Thafar M A, Olayan R S, Ashoor H, et al. DTiGEMS+: Drug-Target Interaction Prediction Using Graph Embedding, Graph Mining, and Similarity-Based Techniques[J]. Journal of Cheminformatics, 2020, 12(1): Article No.44.
(Meng Yan, Wang Yunyun. Research and Analysis of Typical Semi-Supervised Classification Algorithm[J]. Computer Technology and Development, 2017, 27(10): 43-48.)
[12]
王磊. 基于机器学习的药物-靶标相互作用预测研究[D]. 徐州: 中国矿业大学, 2018.
[12]
(Wang Lei. Research on the Prediction of Drug-Target Interactions Based on Machine Learning[D]. Xuzhou: China University of Mining and Technology, 2018.)
[13]
张丽娟. 基于逻辑回归的药物与靶标相互作用关系预测[D]. 长沙: 湖南大学, 2018.
[13]
(Zhang Lijuan. Drug Target Interaction Prediction Based on Logistic Regression[D]. Changsha: Hunan University, 2018.)
[14]
Huang Y A, You Z H, Chen X. A Systematic Prediction of Drug-Target Interactions Using Molecular Fingerprints and Protein Sequences[J]. Current Protein & Peptide Science, 2018, 19(5): 468-478.
[15]
Zheng X P, He S, Song X, et al. DTI-RCNN: New Efficient Hybrid Neural Network Model to Predict Drug-Target Interactions[C]// Proceedings of the 27th International Conference on Artificial Neural. Cham: Springer, 2018: 104-114.
[16]
Cheng F X, Liu C, Jiang J, et al. Prediction of Drug-Target Interactions and Drug Repositioning via Network-Based Inference[J]. PLoS Computational Biology, 2012, 8(5): e1002503.
doi: 10.1371/journal.pcbi.1002503
[17]
Wang W H, Yang S, Li J. Drug Target Predictions Based on Heterogeneous Graph Inference[J]. Pacific Symposium on Biocomputing, 2013: 53-64.
(Li Min, Wang Xiaotong, Luo Huimin, et al. Progress on Random Walk and Its Application in Network Biology[J]. Acta Electronica Sinica, 2018, 46(8): 2035-2048.)
doi: 10.3969/j.issn.0372-2112.2018.08.033
[19]
Chen X, Liu M X, Yan G Y. Drug-Target Interaction Prediction by Random Walk on the Heterogeneous Network[J]. Molecular BioSystems, 2012, 8(7): 1970-1978.
doi: 10.1039/c2mb00002d
pmid: 22538619
[20]
Zheng X D, Ding H, Mamitsuka H, et al. Collaborative Matrix Factorization with Multiple Similarities for Predicting Drug-Target Interactions[C]// Proceedings of the 19th ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. New York: ACM, 2013: 1025-1033.
[21]
Ezzat A, Zhao P L, Wu M, et al. Drug-Target Interaction Prediction with Graph Regularized Matrix Factorization[J]. IEEE/ACM Transactions on Computational Biology and Bioinformatics, 2017, 14(3): 646-656.
doi: 10.1109/TCBB.2016.2530062
pmid: 26890921
[22]
Cui Z, Gao Y L, Liu J X, et al. L2,1-GRMF: An Improved Graph Regularized Matrix Factorization Method to Predict Drug-Target Interactions[J]. BMC Bioinformatics, 2019, 20(Suppl 8): 287.
doi: 10.1186/s12859-019-2768-7
[23]
Yue X, Wang Z, Huang J G, et al. Graph Embedding on Biomedical Networks: Methods, Applications and Evaluations[J]. Bioinformatics, 2020, 36(4): 1241-1251.
doi: 10.1093/bioinformatics/btz718
pmid: 31584634
[24]
Luo Y N, Zhao X B, Zhou J T, et al. A Network Integration Approach for Drug-Target Interaction Prediction and Computational Drug Repositioning from Heterogeneous Information[J]. Nature Communications, 2017, 8: Article No.573.
[25]
Wan F P, Hong L X, Xiao A, et al. NeoDTI: Neural Integration of Neighbor Information from a Heterogeneous Network for Discovering New Drug-Target Interactions[J]. Bioinformatics, 2019, 35(1): 104-111.
doi: 10.1093/bioinformatics/bty543
pmid: 30561548
[26]
Zeng X X, Zhu S Y, Lu W Q, et al. Target Identification Among Known Drugs by Deep Learning from Heterogeneous Networks[J]. Chemical Science, 2020, 11(7): 1775-1797.
doi: 10.1039/c9sc04336e
pmid: 34123272
[27]
Estrada E. Topological Structural Classes of Complex Networks[J]. Physical Review E, 2007, 75(1): 016103.
doi: 10.1103/PhysRevE.75.016103
[28]
Grady L. Random Walks for Image Segmentation[J]. IEEE Transactions on Pattern Analysis and Machine Intelligence, 2006, 28(11): 1768-1783.
doi: 10.1109/TPAMI.2006.233
pmid: 17063682
[29]
van Laarhoven T, Nabuurs S B, Marchiori E. Gaussian Interaction Profile Kernels for Predicting Drug-Target Interaction[J]. Bioinformatics, 2011, 27(21): 3036-3043.
doi: 10.1093/bioinformatics/btr500
pmid: 21893517
[30]
Zhou T, Ren J, Medo M, et al. How to Project a Bipartite Network?[J]. Physical Review E, 2007, 76(4): 046115.
doi: 10.1103/PhysRevE.76.046115
[31]
Zhu X Z, Tian H, Zhang P, et al. Personalized Recommendation Based on Unbiased Consistence[J]. EPL (Europhysics Letters), 2015, 111(4): 48007.
doi: 10.1209/0295-5075/111/48007
[32]
Deshpande M, Karypis G. Item-Based Top-N Recommendation Algorithms[J]. ACM Transactions on Information Systems, 2004, 22(1): 143-177.
doi: 10.1145/963770.963776
[33]
Drugbank: Version 5.1.5[DB/OL]. (2020-01-03) [2020-01-30]. https://www.drugbank.ca/.
[34]
Human Protein Reference Database: Version 9[DB/OL]. (2010-04-13) [2020-01-30]. http://www.hprd.org/.
[35]
Comparative Toxicogenomics Database: Version 15982[DB/OL]. (2020-01-08) [2020-01-30]. http://ctdbase.org/.
[36]
Valdeolivas A, Tichit L, Navarro C, et al. Random Walk with Restart on Multiplex and Heterogeneous Biological Networks[J]. Bioinformatics, 2019, 35(3): 497-505.
doi: 10.1093/bioinformatics/bty637
pmid: 30020411
[37]
Lauterbach E C. Psychotropic Drug Effects on Gene Transcriptomics Relevant to Parkinson's Disease[J]. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2012, 38(2): 107-115.
[38]
Zlatković J, Todorović N, Tomanović N, et al. Chronic Administration of Fluoxetine or Clozapine Induces Oxidative Stress in Rat Liver: A Histopathological Study[J]. European Journal of Pharmaceutical Sciences, 2014, 59: 20-30.
doi: 10.1016/j.ejps.2014.04.010
pmid: 24768740
[39]
Orsetti M, Di Brisco F, Rinaldi M, et al. Some Molecular Effectors of Antidepressant Action of Quetiapine Revealed by DNA Microarray in the Frontal Cortex of Anhedonic Rats[J]. Pharmacogenetics and Genomics, 2009, 19(8): 600-612.
doi: 10.1097/FPC.0b013e32832ee573
pmid: 19587612
[40]
de Berardis D, Vellante F, Pettorruso M, et al. Suicide and Genetic Biomarkers: Toward Personalized Tailored-Treatment with Lithium and Clozapine[J]. Current Pharmaceutical Design, 2021, 27(30): 3293-3304.
doi: 10.2174/1381612827666210603143353
pmid: 34082673
[41]
Tatham E L, Hall G B C, Clark D, et al. The 5-HTTLPR and BDNF Polymorphisms Moderate the Association Between Uncinate Fasciculus Connectivity and Antidepressants Treatment Response in Major Depression[J]. European Archives of Psychiatry and Clinical Neuroscience, 2017, 267(2): 135-147.
doi: 10.1007/s00406-016-0702-9
pmid: 27277475
[42]
Korolev A O, Kalinina T S, Volkova A V, et al. Role of GABAA Receptors in the Mechanism of in Vivo Psychotropic Activity of Amitriptyline in Rats[J]. Bulletin of Experimental Biology and Medicine, 2020, 168(3): 341-344.
doi: 10.1007/s10517-020-04704-0
pmid: 31940131
[43]
Xu Q, Wu X, Li M, et al. Association Studies of Genomic Variants with Treatment Response to Risperidone, Clozapine, Quetiapine and Chlorpromazine in the Chinese Han Population[J]. The Pharmacogenomics Journal, 2016, 16(4): 357-365.
doi: 10.1038/tpj.2015.61
[44]
Yatham L N, Sossi V, Ding Y S, et al. A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR[J]. The International Journal of Neuropsychopharmacology, 2018, 21(2): 108-113.
doi: 10.1093/ijnp/pyx066
[45]
Yoo S, Kim M Y, Cho J Y. Syk and SRC-Targeted Anti-Inflammatory Activity of Aripiprazole, an Atypical Antipsychotic[J]. Biochemical Pharmacology, 2018, 148: 1-12.
doi: S0006-2952(17)30710-4
pmid: 29241811
[46]
Zhou M S, Wang Q Q, Zheng C L, et al. Drug Repurposing for Opioid Use Disorders: Integration of Computational Prediction, Clinical Corroboration, and Mechanism of Action Analyses[J]. Molecular Psychiatry, 2021, 26(9): 5286-5296.
doi: 10.1038/s41380-020-01011-y
pmid: 33432189
[47]
Stark A D, Jordan S, Allers K A, et al. Interaction of the Novel Antipsychotic Aripiprazole with 5-HT1A and 5-HT2A Receptors: Functional Receptor-Binding and in Vivo Electrophysiological Studies[J]. Psychopharmacology, 2007, 190(3): 373-382.
doi: 10.1007/s00213-006-0621-y
(Li Ke, Yu Lanxiu, Liu Xiaoyu, et al. Research Progress on Improving Sleep Mechanism of γ-Aminobutyric Acid[J]. Science and Technology of Food Industry, 2019, 40(14):353-358.)